| Dr John F Schonder, MD | |
|
601 John St, Ste 100, Kalamazoo, MI 49007-5341 | |
| (269) 373-1592 | |
| (269) 373-6270 |
| Full Name | Dr John F Schonder |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 25 Years |
| Location | 601 John St, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184644114 | NPI | - | NPPES |
| 1184644114 | Medicaid | MI | |
| 1417961137 | Other | MI | BCBSM - BRONSON |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 4301075462 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bronson Methodist Hospital | Kalamazoo, MI | Hospital |
| Bronson Battle Creek Hospital | Battle creek, MI | Hospital |
| Bronson Lakeview Hospital | Paw paw, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bronson Methodist Hospital | 0244148633 | 598 |
| Bronson Battle Creek Hospital | 0547173478 | 157 |
News Archive
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.
In the eastern US, risk of contracting Lyme disease is higher in fragmented forests with high rodent densities and low numbers of resident fox, opossum, and raccoons.
An Evolutionary Biologist at The University of Manchester, working with scientists in the United States, has found compelling evidence that parts of the brain can evolve independently from each other. It's hoped the findings will significantly advance our understanding of the brain.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.
› Verified 5 days ago
| Entity Name | Bronson Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.
In the eastern US, risk of contracting Lyme disease is higher in fragmented forests with high rodent densities and low numbers of resident fox, opossum, and raccoons.
An Evolutionary Biologist at The University of Manchester, working with scientists in the United States, has found compelling evidence that parts of the brain can evolve independently from each other. It's hoped the findings will significantly advance our understanding of the brain.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.
› Verified 5 days ago
| Entity Name | Bronson South Haven Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174749170 PECOS PAC ID: 6204724834 Enrollment ID: O20040305001005 |
News Archive
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.
In the eastern US, risk of contracting Lyme disease is higher in fragmented forests with high rodent densities and low numbers of resident fox, opossum, and raccoons.
An Evolutionary Biologist at The University of Manchester, working with scientists in the United States, has found compelling evidence that parts of the brain can evolve independently from each other. It's hoped the findings will significantly advance our understanding of the brain.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.
› Verified 5 days ago
| Entity Name | Bronson Battle Creek Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093119638 PECOS PAC ID: 0547173478 Enrollment ID: O20041103000774 |
News Archive
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.
In the eastern US, risk of contracting Lyme disease is higher in fragmented forests with high rodent densities and low numbers of resident fox, opossum, and raccoons.
An Evolutionary Biologist at The University of Manchester, working with scientists in the United States, has found compelling evidence that parts of the brain can evolve independently from each other. It's hoped the findings will significantly advance our understanding of the brain.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.
› Verified 5 days ago
| Entity Name | Bronson Lakeview Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235131137 PECOS PAC ID: 9032008495 Enrollment ID: O20051027001022 |
News Archive
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.
In the eastern US, risk of contracting Lyme disease is higher in fragmented forests with high rodent densities and low numbers of resident fox, opossum, and raccoons.
An Evolutionary Biologist at The University of Manchester, working with scientists in the United States, has found compelling evidence that parts of the brain can evolve independently from each other. It's hoped the findings will significantly advance our understanding of the brain.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John F Schonder, MD 601 John St, Suite 100, Kalamazoo, MI 49007-5341 Ph: (269) 373-1592 | Dr John F Schonder, MD 601 John St, Ste 100, Kalamazoo, MI 49007-5341 Ph: (269) 373-1592 |
News Archive
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.
In the eastern US, risk of contracting Lyme disease is higher in fragmented forests with high rodent densities and low numbers of resident fox, opossum, and raccoons.
An Evolutionary Biologist at The University of Manchester, working with scientists in the United States, has found compelling evidence that parts of the brain can evolve independently from each other. It's hoped the findings will significantly advance our understanding of the brain.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.
› Verified 5 days ago
Dr. Eric S Shay, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Suite M-170, Kalamazoo, MI 49007 Phone: 269-381-5060 Fax: 269-381-1655 | |
Michael Trexler, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1521 Gull Rd, Suite 173, Kalamazoo, MI 49048 Phone: 269-226-5165 | |
Dr. Christopher Rogers, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Ste 100, Kalamazoo, MI 49007 Phone: 269-373-1222 Fax: 269-373-6270 | |
Desmonda Brady Wixson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4613 W Main St Ste A, Kalamazoo, MI 49006 Phone: 269-488-8672 Fax: 269-488-8673 | |
Dr. Kevin L. Beyer, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1535 Gull Rd, Suite 105, Kalamazoo, MI 49048 Phone: 269-385-9900 Fax: 269-385-2140 | |
Ernest Lee Yoder, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Oakland Dr, Kalamazoo, MI 49008 Phone: 269-337-6300 | |
Valerie Siqueira Duhn, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 521 E. Michigan Ave, Ste 201, Kalamazoo, MI 49007 Phone: 269-349-6759 Fax: 369-349-7450 |